Cite
MLA Citation
Régis Peffault de Latour et al.. “Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial.” Lancet, vol. 9, no. 9, 2022, pp. e648–e659. http://access.bl.uk/ark:/81055/vdc_100164416497.0x00000a